On the stock market since 2021, it operates in the world of money and finance. Now — the numbers.
An investor who bought at the very peak is down 97% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.
The stock sits at $0.43. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 2/100. For a turnaround signal, the stock first needs to close the gap with the market.
On our five-subject report card, BIOT sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: BIOT is a high-risk stock — not yet profitable, and its future rides on its product catching on.